Please ensure Javascript is enabled for purposes of website accessibility

3 Top Stocks that Are Cash Cows

By Keith Speights – Jul 8, 2017 at 12:03PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Looking for stocks spinning off lots of cash? Check out Alphabet, Apple, and Johnson & Johnson.

You've probably heard the expression "cash cow," but what does it really mean? The metaphor comes from the dairy industry, where a farmer buys a cow and then receives a steady supply of milk for years to come. In the business world, the equivalent is a company that consistently generates solid cash flow.

Stocks with strong free cash flow (the amount of cash remaining after capital expenditures) often make great investment choices. They're more likely to pay out dividends and to keep those dividends coming. The companies also have more flexibility in reinvesting in their businesses to remain competitive.

Three top stocks that are definitely cash cows are Alphabet (GOOG -1.98%) (GOOGL -1.82%), Apple (AAPL -3.00%), and Johnson & Johnson (JNJ -0.71%). Here's how they make their big moola (sorry -- the pun was too hard to resist).

Cow outline made up of dollar signs

Image source: Getty Images.


Alphabet's free cash flow over the last 12 months totaled almost $28 billion. This great cash flow helped Google report cash, cash equivalents, and marketable securities of $92.4 billion at the end of the first quarter. 

How does Alphabet generate its enormous cash flow? Nearly all of it (99%) comes from Google, with a small portion stemming from what the company calls its "other bets," which include Nest home automation and its Verily life sciences division. Within Google, advertising revenue on its search engine and YouTube social media site account for roughly 87% of revenue.

What's particularly great for Alphabet is that its free cash flow continues to grow. Sooner or later, the company will need to do something with the big cash stockpile that it has accumulated. Most likely, Alphabet will make strategic acquisitions, buy back more shares, and/or initiate a dividend. Any of these will reward investors, making Alphabet one of the most attractive cash cow stocks on the market.


Apple generated free cash flow over the last 12 months of nearly $53 billion. Thanks to this strong cash flow, Apple claims a massive cash stockpile totaling $67.1 billion (including cash, cash equivalents, and marketable securities). The company's cash flow also enables it to pay a dividend with a current yield of 1.76%.

While Apple makes money from many popular products and services, its iPhone sales generate 63% of total revenue. This could change in the future, though. One venture capital firm founder thinks that Apple could be developing augmented reality glasses that could be even bigger than the iPhone

Apple iPhones

Image source: Apple. 

Also, Apple's iPhone sales are only growing by single-digit percentages. By comparison, revenue from the company's second-biggest moneymaker -- services, which includes digital content, AppleCare, Apple Pay, and licensing -- jumped 18% year over year in the first quarter of 2017. Although Apples faces some risks from competition, it seems likely that the company will remain a cash cow for years to come.

Johnson & Johnson

Johnson & Johnson's free cash flow over the last 12 months topped $16 billion. The healthcare giant reported cash, cash equivalents, and marketable securities of $39.3 billion at the end of March. J&J's dividend is one of the most solid in all of healthcare, with a current yield of 2.53% and a 54-year streak of dividend increases.

There isn't much in healthcare that J&J doesn't do. The company's top source of revenue is its pharmaceutical business, which generates around 46% of total sales. Its medical devices segment isn't too far behind, contributing more than 35% of total revenue. J&J's consumer business kicks in the rest of the company's sales.

The company has prioritized acquisitions as a key way of using its cash and cash flow. Earlier this year, J&J acquired Abbott Medical Optics from Abbott Laboratories, bolstering its medical devices business. More recently, the company completed its $30 billion acquisition of Swiss drugmaker Actelion. Although there have been quite a few questions about the price tag paid for Actelion, J&J seems poised to stay ranked as a top cash cow stock. 

Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Keith Speights owns shares of Alphabet (A shares) and Apple. The Motley Fool owns shares of and recommends Alphabet (A shares), Alphabet (C shares), Apple, and Johnson & Johnson. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Johnson & Johnson Stock Quote
Johnson & Johnson
$163.36 (-0.71%) $-1.17
Apple Inc. Stock Quote
Apple Inc.
$138.20 (-3.00%) $-4.28
Alphabet Inc. Stock Quote
Alphabet Inc.
$95.65 (-1.82%) $-1.77
Abbott Laboratories Stock Quote
Abbott Laboratories
$96.76 (-1.56%) $-1.53
Alphabet Inc. Stock Quote
Alphabet Inc.
$96.15 (-1.98%) $-1.94

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/01/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.